Multidrug level of resistance (MDR) is among the leading factors behind treatment failure in cancer chemotherapy. of P-gp to [3H]-paclitaxel and it didn’t impact both the expression and cellular localization of P-gp based on Western blot and immunofluorescent analysis. Furthermore, glesatinib can stimulate ATPase in a dose-dependent manner. The docking study indicated that glesatinib interacted… Continue reading Multidrug level of resistance (MDR) is among the leading factors behind